Israel Englander’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-50,000
Closed -$1.17M 5974
2026
Q1
$1.17M Buy
50,000
+21,800
+77% +$679K ﹤0.01% 4281
2025
Q4
$1.25M Sell
28,200
-52,100
-65% -$2.92M ﹤0.01% 4328
2025
Q3
$5.87M Buy
80,300
+17,400
+28% +$1.13M ﹤0.01% 2973
2025
Q2
$3.86M Sell
62,900
-91,600
-59% -$5.11M ﹤0.01% 3248
2025
Q1
$8.97M Buy
154,500
+81,000
+110% +$5.11M ﹤0.01% 2298
2024
Q4
$3.92M Buy
73,500
+50,300
+217% +$2.46M ﹤0.01% 3043
2024
Q3
$1.01M Buy
+23,200
New +$774K ﹤0.01% 4270

Other funds holding DOCS

Israel Englander's DOCS Position: Q2 2026 in Review

Israel Englander increased its Doximity (DOCS) stake by 361% in Q2 2026, buying an estimated $35.8M and bringing the position to 2,068,601 shares worth $42.9M. The position accounts for 0.02% of the portfolio, ranked #995.

Israel Englander first reported a position in DOCS in Q2 2021 and has held it in 17 quarters since. The position peaked at $48.3M in Q3 2025. 355 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Israel Englander held 2,068,601 shares of Doximity worth $42.9M as of Q2 2026.
  • Israel Englander bought 1,619,819 Doximity shares in Q2 2026, an estimated $35.8M.
  • Doximity made up 0.02% of Israel Englander's portfolio in Q2 2026, its #995 holding.
  • Israel Englander first reported a position in Doximity in Q2 2021 and has held it in 17 quarters since.
  • Israel Englander's Doximity position peaked at $48.3M in Q3 2025.
  • 355 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.